All Stories

  1. Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal women

    Article • Journal of Drug Assessment, January 2019, Taylor & Francis

    Dr E Michael Lewiecki

  2. New and emerging concepts in the use of denosumab for the treatment of osteoporosis

    Article • Therapeutic Advances in Musculoskeletal Disease, October 2018, SAGE Publications

    Dr E Michael Lewiecki

  3. Better osteoporosis care, closer to home, at lower cost

    Article • Journal of the Endocrine Society, November 2017, Endocrine Society

    Dr E Michael Lewiecki

  4. Corrigendum to “New and Emerging Therapies for Osteoporosis”

    Article • Journal of Osteoporosis, January 2017, Hindawi Publishing Corporation

    Dr E Michael Lewiecki

  5. Bone Health ECHO: Telementoring to Improve Osteoporosis Care

    Article • Women s Health, January 2016, SAGE Publications

    Dr E Michael Lewiecki

  6. Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis

    Article • International Journal of Women s Health, June 2015, Dove Medical Press

    Dr E Michael Lewiecki

  7. Biological therapy: chronicling 15 years of progress

    Article • Expert Opinion on Biological Therapy, February 2015, Informa Healthcare

    Dr E Michael Lewiecki

  8. Denosumab for the treatment of osteoporosis

    Article • Expert Opinion on Drug Metabolism & Toxicology, January 2015, Informa Healthcare

    Dr E Michael Lewiecki

  9. Monitoring Therapy for Osteoporosis

    Article • August 2013, Wiley

    Dr E Michael Lewiecki

  10. Evaluation of the Patient at Risk for Osteoporosis

    Article • January 2013, Elsevier

    Dr E Michael Lewiecki

  11. Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis

    Article • Drug Healthcare and Patient Safety, December 2011, Taylor & Francis

    Dr E Michael Lewiecki

  12. Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis

    Article • Therapeutics and Clinical Risk Management, October 2009, Taylor & Francis

    Dr E Michael Lewiecki

  13. Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect

    Article • Core Evidence, June 2009, Taylor & Francis

    Dr E Michael Lewiecki

  14. Denosumab: an investigational drug for the management of postmenopausal osteoporosis

    Article • Biologics Targets & Therapy, August 2008, Taylor & Francis

    Dr E Michael Lewiecki

  15. DXA Quality Matters

    Article • Journal of Clinical Densitometry, October 2006, Elsevier

    Dr E Michael Lewiecki